Klaus Ley Receives $2.3 Million to Study Fundamentals of Immune Cell Activation
LA JOLLA—Scientists at La Jolla Institute for Immunology (LJI) have received a new grant of more than $2.3 million from the National
LA JOLLA—Scientists at La Jolla Institute for Immunology (LJI) have received a new grant of more than $2.3 million from the National
Preliminary data from our lab shows that vascular endothelial cells (vECs) mount remarkably potent innate responses to cell-free DNA, which
Immunotherapies for head and neck cancer: To develop new cancer therapies by studying how the immune system, by way of
Sonia Sharma, Ph.D., and her lab members lead unbiased, genome-scale approaches to unravel innate immunity, the body’s early immune response to microbial pathogens and neoplastic cells.
Stephen Schoenberger, Ph.D., is focused on achieving a mechanistic understanding of the generation and regulation of T cell responses in the context of in vivo infection and tumor development.
LA JOLLA, CA—Scientists at the La Jolla Institute for Immunology (LJI) have discovered a potential new way to better fight
Rebecca and Sandy Shapery embody that transformation, and they hope their inspirational journey will soon help save the lives of
But Aldrich was not a normal patient. After the retired entrepreneur learned he had metastatic adenocarcinoma of the esophagus and
LA JOLLA, CA—A subtype of T cells called T regulatory cells are major players in two front-page health issues: autoimmune
LA JOLLA, CA – A growing number of cancer patients are being offered a promising new treatment called CAR T
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) and UC San Diego have been awarded $ 4.5 million